arrow
D

Darrell H. S. Tan

saint michaels hospital toronto
H指数:35
被引数:7,234

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disentangling Between- and Within-Person Effects of HIV PrEP and Treatment Attitudes on Condom Use and Bacterial STIs Among Sexual Minority Men

区分男同性恋者中HIV PrEP和治疗方案态度对安全套使用和细菌性性传播感染之间的个体间和个体内效应

2026-09-180
PRE
Human Papillomavirus Vaccine Effectiveness Against Prevalent Human Papillomavirus by Age, Years Sexually Active Before Vaccination, and HIV Status in Gay, Bisexual, and Other Men Who Have Sex With Men, 2019–2021

人乳头瘤病毒疫苗对男男性行为者中流行型人乳头瘤病毒的保护效果,按年龄、接种疫苗前的性行为活跃年限及HIV状态分析,2019–2021

2026-08-260
OAAI
Incidence and risk factors of C. trachomatis, N. gonorrhoeae and syphilis among a cohort of urban Canadian gay, bisexual and other men who have sex with men, 2017-2023: informing the potential impact of doxycycline prophylaxis

2017-2023年加拿大城市男男性行为者队列中沙眼衣原体、淋病奈瑟菌和梅毒的发病率和危险因素:为多西环素预防的潜在影响提供信息

2026-05-250
PRE
Substance Use Disorders and Related Hospitalizations and Mortality among Gay, Bisexual, and Other Men Who Have Sex with Men: A Matched Cohort Study

物质使用障碍及相关的住院和死亡情况在男同性恋者、男双性恋者和有同性性行为的其他男性中的研究:一项匹配队列研究

2026-04-090
OAAI
Comparison of Estradiol Concentrations Between Transgender Women Taking Oral Estrogen-Based Gender-Affirming Hormone Therapy With and Without Concurrent Bictegravir/Tenofovir Alafenamide/Emtricitabine

比较口服雌激素为基础的性别肯定激素治疗的跨性别女性中,使用与未使用联合比克替拉韦/替诺福韦艾拉酚胺/恩曲他滨的雌二醇浓度对比

2026-01-010
PRE
Using a paper-based checklist for promoting increased access to long-acting injectable cabotegravir/rilpivirine among people living with HIV in Toronto: Lessons learned from a quality improvement initiative

使用纸质检查表促进多伦多HIV感染者对长效注射用卡博特格拉韦/利匹韦林的获取增加:一项质量改进倡议的经验教训

2025-12-010
PRE
Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada

在加拿大安大略省针对猴痘(mpox)疫情公共卫生应对措施中,完成完整两剂猴痘疫苗接种方案的个体特征。

2025-11-260
PRE
The impact of Undetectable=Untransmittable and viral suppression on condomless sex among mixed HIV-status couples in Canada

在加拿大混合HIV状况伴侣中,无保护性行为受到"检测不到即不具传染性"(Undetectable=Untransmittable)和病毒抑制的影响。

2025-10-090
PRE
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process

建立长效注射用卡博格韦和 rilpivirine 治疗的病毒学失败和停药共享定义(CONSENSUS-LAI 研究):一项国际调查和德尔菲过程

2025-08-040
OAAI
Monkeypox Virus Transcriptional Profiles and Host Responses in Skin Lesion Swabs Among Individuals With Human Immunodeficiency Virus

猴痘病毒转录谱及人类免疫缺陷病毒感染者皮肤损伤拭子中的宿主反应

2025-07-010
OAAI
Racial disparities in HIV pre-exposure prophylaxis (PrEP) awareness and uptake among white, Black, and Indigenous men in Canada: Analysis of data from the I'm Ready national HIV self-testing study

加拿大白人、黑人及原住民男性中HIV暴露前预防(PrEP)认知与接受度的种族差异:基于“我准备好了”全国HIV自我检测研究的数据分析

2025-03-190
OA
Early clinical experience using tecovirimat during the 2022 mpox epidemic in Toronto underscores ongoing clinical equipoise and the need for randomized trials

在多伦多2022 mpox流行期间使用tecovimat的早期临床经验强调了持续的临床平衡和随机试验的必要性

2025-02-170
OAAI